SNAP2
Optimising the management of blood pressure following hypertensive pregnancy to reduce cardiovascular risk.
Background and study aims
To develop and test the clinical and cost-effectiveness of an intervention to support self-management of antihypertensive medication following a hypertensive pregnancy. The intervention aims to improve long-term BP control and therefore reduce adverse cardiovascular outcomes and the associated costs to the NHS.
How is the SNAP2 trial addressing health inequalities?
We will provide updates on our sample population on this website. Click here to view our Health Equity Stream.
Who can participate?
Women in the postnatal period, requiring antihypertensive treatment
What does the study involve?
The intervention involves BP self-monitoring using a validated blood pressure monitor and self-titration of antihypertensive therapy guided by digital intervention, overseen by a supervising clinician.
Interested in finding out more about this study?
If you are a healthcare professional, researcher or someone interested in taking part, please find more resources and information about the study by clicking the relevant panel on the right side of this page.
Click here for study updates and more.
Contact Details
snap2trial@phc.ox.ac.uk
Trial Team
-
-
-
Elaine Egden
Clinical Trials Co-ordinator
Oxford Co-Investigators
External Co-Investigators
Professor Lucy Yardley (University of Bristol)
Professor Debra Bick (University of Warwick)
Professor Jenny Myers (University of Manchester)
Professor Lucy Chappell (King’s College London)
Professor Christine McCourt (City, University of London)
Dr Lucy Mackillop (Oxford University Hospitals Foundation Trust)
Marcus Green (Action on Pre-eclampsia Limited)
Sandra Igwe (The Motherhood Group Limited)
Funding Details:
NIHR Collaboration for Leadership in Applied Health Research and Care Oxford
REC number: 24/SC/0071 • IRAS number: 332333
Study period: January 2024 – July 2026
